Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimal timing of recombinant herpes zoster virus vaccination for a JAK inhibitor treatment in rheumatoid arthritis: a multicentre, open-label, randomised comparative study (STOP-HZ study): study protocol.
Takanashi S, Ohmura K, Misaki K, Ihata A, Matsui T, Tohma S, Saegusa J, Sato S, Matsubara T, Yamaoka K, Amano K, Miyamoto T, Mori Y, Kaneko Y. Takanashi S, et al. Among authors: amano k. BMJ Open. 2024 Nov 17;14(11):e090668. doi: 10.1136/bmjopen-2024-090668. BMJ Open. 2024. PMID: 39551586 Free PMC article.
Effects of switching to dolutegravir/lamivudine from tenofovir alafenamide fumarate/emtricitabine/dolutegravir or abacavir/lamivudine/dolutegravir on body weight and lipid profile in Japanese people living with HIV.
Ikegaya K, Muramatsu T, Sekiya R, Sekine Y, Harada Y, Miyashita R, Yamaguchi T, Ichiki A, Chikasawa Y, Bingo M, Yotsumoto M, Hagiwara T, Amano K, Takeuchi H, Kinai E. Ikegaya K, et al. Among authors: amano k. J Infect Chemother. 2024 Oct 22:S1341-321X(24)00291-5. doi: 10.1016/j.jiac.2024.10.012. Online ahead of print. J Infect Chemother. 2024. PMID: 39447868 Free article.
Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort.
Katsumata Y, Sada KE, Kameda T, Dobashi H, Kaname S, Tsuboi N, Matsumoto Y, Amano K, Tamura N, Harigai M; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan; Members of the Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan: In addition to the authors, the following investigators and institutions participated in this study:. Katsumata Y, et al. Among authors: amano k. Immunol Med. 2024 Oct 11:1-11. doi: 10.1080/25785826.2024.2408054. Online ahead of print. Immunol Med. 2024. PMID: 39391948 Free article.
Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A.
Miura K, Shukuya T, Furuya N, Morita R, Kisohara A, Mouri A, Watanabe S, Tanaka H, Hirata A, Hakozaki T, Hamai K, Matsumoto N, Watanabe K, Ashinuma H, Miyauchi E, Sugano K, Hosokawa S, Amano K, Morita S, Kobayashi K, Maemonodo M, Takahashi K. Miura K, et al. Among authors: amano k. J Cachexia Sarcopenia Muscle. 2024 Oct 1. doi: 10.1002/jcsm.13606. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 39351653 Free article.
1,357 results